Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Trading Down 2.7% – Should You Sell?

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) shares were down 2.7% during trading on Friday . The company traded as low as $35.39 and last traded at $35.47. Approximately 27,668 shares were traded during mid-day trading, a decline of 6% from the average session volume of 29,503 shares. The stock had previously closed at $36.45.

Invesco Nasdaq Biotechnology ETF Stock Performance

The stock has a 50-day moving average price of $33.42 and a two-hundred day moving average price of $30.74. The stock has a market capitalization of $83.00 million, a PE ratio of 17.03 and a beta of 0.60.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 26th. Stockholders of record on Monday, June 22nd were given a dividend of $0.0342 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Monday, June 22nd.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of IBBQ. Ascentis Independent Advisors purchased a new stake in Invesco Nasdaq Biotechnology ETF in the 1st quarter worth $31,000. Royal Bank of Canada purchased a new position in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at about $37,000. International Assets Investment Management LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter worth about $41,000. Advisory Services Network LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF in the third quarter worth about $52,000. Finally, Osaic Holdings Inc. grew its position in shares of Invesco Nasdaq Biotechnology ETF by 28.4% during the second quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after purchasing an additional 1,052 shares in the last quarter.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.